Eigen-guided transformer: A data-driven approach for chronic kidney disease forecasting.

Area of Science:

• Biomedical Informatics
• Artificial Intelligence in Medicine
• Nephrology

Background:

• Accurate prediction of Chronic Kidney Disease (CKD) is crucial for timely intervention but challenging due to complex patient data.
• Current deep learning models for disease prediction often lack interpretability and computational efficiency, acting as 'black boxes'.

Purpose of the Study:

• To introduce the Eigen-Guided Transformer, an innovative deep learning architecture designed to improve the interpretability and efficiency of CKD prediction.
• To address the limitations of existing models by incorporating data-driven eigenvalue analysis for enhanced model topology and feature interaction understanding.

Main Methods:

• Developed the Eigen-Guided Transformer architecture, optimizing attention heads via intrinsic dimensionality analysis (h=11).
• Employed eigenvector-informed weight initialization and validation-driven depth optimization for model construction.
• Utilized Monte Carlo Dropout for uncertainty quantification and performed demographic fairness audits.

Main Results:

• Achieved superior performance in creatinine prediction on the MIMIC-IV dataset (MSE 0.089 ± 0.004, MAE 0.132 ± 0.0001), outperforming the Transformer (TFT) by 11.1%.
• Demonstrated exceptional parameter efficiency with a FLOPs/accuracy ratio of 142.4M, significantly lower than TFT and Autoformer.
• Showcased strong cross-institutional generalizability on the eICU dataset (MSE 0.0117 ± 0.0001, MAE 0.0254 ± 0.0008) and equitable performance across demographic groups.

Conclusions:

• The Eigen-Guided Transformer provides a transparent, efficient, and reliable approach for individualized Chronic Kidney Disease risk prediction.
• This model's ability to match attention mechanisms with biological data structures offers a promising paradigm for personalized renal disease therapy.
• The model's interpretability and validated generalizability support its potential for clinical implementation in managing chronic kidney disease.